Skip to main content
. 2021 Mar 11;139(5):508–515. doi: 10.1001/jamaophthalmol.2021.0114

Table 2. Participant Perceptions Regarding Health Risks During the COVID-19 Pandemic.

Variable All (n = 348) Site P value for Emory vs Kellogg Condition P value for AMD vs DR
Emory (n = 226) Kellogg (n = 122) AMD (n = 238) DR (n = 110)
Concern of permanent vision loss due to missed appointments from pandemic, No. (%)
Very or moderately concerned 163 (47) 108 (48) 55 (45) .62a 108 (45) 55 (50) .27a
Somewhat concerned 39 (11) 26 (12) 13 (11) 25 (11) 14 (13)
Slightly or not at all concerned 145 (42) 91 (40) 54 (44) 104 (44) 41 (37)
Perceived likelihood of being exposed to COVID-19 at eye clinic, No. (%) NA NA NA NA NA NA .001a
Extremely likely or likely 49 (14) 38 (17) 11 (9) .85a 29 (12) 20 (18) .13b
Neutral 91 (26) 52 (23) 39 (32) 52 (22) 39 (35) .007b
Unlikely or extremely unlikely 208 (60) 136 (60) 72 (59) 157 (66) 51 (46) .001b
Risk of exposure would be willing to accept to maintain vision, No. (%) NA NA NA .006a NA NA NA
1 in 10 or 1 in 100 179 (51) 127 (57) 52 (43) .016b 129 (54) 50 (45) .27a
1 in 1000 or 1 in 10 000 67 (19) 37 (17) 30 (25) .06b 39 (16) 28 (25)
1 in 100 000 or 1 in 1 000 000 23 (7) 13 (6) 10 (8) .38b 15 (6) 8 (7)
Not willing to assume any risk 72 (21) 44 (20) 28 (23) .44b 50 (21) 22 (20)

Abbreviations: AMD, age-related macular degeneration; COVID-19, coronavirus disease 2019; DR, diabetic retinopathy; NA, not applicable.

a

Mann-Whitney U test used.

b

χ2 Test for independence used to compare individual responses.